03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Apo-Allopurinol 300mg : | |
Type | Medicine Authorised |
Originator | Zyloric 300mg |
Agent | Promopharm |
Distributor | Promopharm |
Laboratory | Apotex |
Responsible Party | Apotex Inc |
Origin | Canada |
Manufacturer | Apotex Inc |
Manufacturing Type | G |
Origin | Canada |
ATC | M04AA01 |
Apo-Allopurinol 300mg :
Apo-Allopurinol 300mg :
Apo-Allopurinol 300mg :
Apo-Allopurinol 300mg :
Apo-Allopurinol 300mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Apo-Allopurinol 300mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Agranulocytosis | Very rare |
Alopecia | Very rare |
Anaphylactic shock | Very rare |
Angina | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Aplastic anemia | Very rare |
Arthralgia (Pain joint) (Joint ache) | Rare |
Asthenia | Very rare |
Ataxia | Very rare |
Bradycardia | Very rare |
Cataract | Very rare |
Change of bowel habit | Very rare |
Coma | Very rare |
Depression | Very rare |
Diabetes mellitus | Very rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very rare |
Eosinophilia | Rare |
Erectile dysfunction | Very rare |
Fever | Very rare |
Fixed drug eruption | Very rare |
Furunculosis | Very rare |
Gynecomastia (Gynaecomastia) | Very rare |
Haematemesis | Very rare |
Haematuria (Hematuria) | Very rare |
Hair discoloration | Very rare |
Headache | Very rare |
Hepatic necrosis | Rare |
Hepatitis | Rare |
Hepatitis granulomatous | Rare |
Hyperlipidaemia | Very rare |
Hypersensitivity reactions | Uncommon |
Hypertension | Very rare |
Infertility male | Very rare |
Liver function test increased | Uncommon |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Lymphadenopathy | Very rare |
Malaise | Very rare |
Nausea | Uncommon |
Neuropathy | Very rare |
Oedema | Very rare |
Paraesthesia (paresthesia) | Very rare |
Paralysis | Very rare |
Renal impairment | Not known |
Seizures | Very rare |
Skin exfoliation (Flaking skin) | Rare |
Skin rash | Common |
Somnolence | Very rare |
Steatorrhoea (Fatty stools) | Very rare |
Stevens-Johnson syndrome | Rare |
Stomatitis | Very rare |
Thrombocytopenia (Thrombopenia) | Very rare |
Uremia | Very rare |
Vertigo | Very rare |
Visual impairment | Very rare |
Vomiting | Uncommon |
Apo-Allopurinol 300mg :
Apo-Allopurinol 300mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Apo-Allopurinol 300mg MoH 975 :
Form | Tablet |
Packaging | Bottle |
Package Size | Box of 100 |
Strength | 300mg |
Public Price | 626230.6 L.L. |
Stratum | A1 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | MP CB 581/91 |
Submission date | 01/01/1991 |
Registration Year | 1992 |
Barcode | 771313215794 |
Price Comparison
● Country: | Lebanon | |
● Form: | Tablet | |
● Package Size: | Box of 100 | |
● Public Price: | 626230.6 LBP | ( 626,230.60 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 6262,31 LBP | ( 6,262.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | The Netherlands | |
● Package Size: | 100 | |
● Public Price: | 16.19 EUR | ( 1,568,422.44 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 0,1619 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 9.19 EUR | ( 890290.44 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 500 tab |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 31/01/2018 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File